ライフサイエンスコーパス: suppressor cell

1 Con A hepatitis, suggesting inhibition of a suppressor cell.

2 d granulocytic and monocytic myeloid-derived suppressor cells.

3 on of T regulatory cells and myeloid-derived suppressor cells.

4 ne suppressive activities of myeloid-derived suppressor cells.

5 lls, regulatory T cells, and myeloid-derived suppressor cells.

6 severely depressed numbers of lung CD8(+) T suppressor cells.

7 aematopoietic progenitor and myeloid-derived suppressor cells.

8 to induce the generation of CD8(+)CD28(-) T suppressor cells.

9 r-associated macrophages and myeloid-derived suppressor cells.

10 y exhibit characteristics of myeloid-derived suppressor cells.

11 velopment, survival, and function of myeloid suppressor cells.

12 ncer: regulatory T cells and myeloid-derived suppressor cells.

13 -DC, DC-10, and PGE2-induced myeloid-derived suppressor cells.

14 ressed on tumor infiltrating myeloid-derived suppressor cells.

15 (+) macrophages and Ly-6C(+) myeloid-derived suppressor cells.

16 gest that these cells may be myeloid derived suppressor cells.

17 effects by the elimination of CD38(+) immune-suppressor cells.

18 ored more M2 macrophages and myeloid-derived suppressor cells.

19 associated with expansion of myeloid-derived suppressor cells.

20 Myeloid-derived suppressor cells, a group of immature neutrophils recent

21 owever, in vivo depletion of myeloid-derived suppressor cells abrogated both Treg expansion and prote

22 ith cancer and in animal tumor models, these suppressor cells accumulate in the tumor microenvironmen

23 innate immunity and impaired myeloid-derived suppressor cell activation.

24 enograft assays to establish that the tumour suppressor Cell adhesion molecule 1 (CADM1) inhibits SqC

25 Depletion of neutrophils/myeloid-derived suppressor cells also suppressed metastasis suggesting a

26 ng the presence of monocytic myeloid-derived suppressor cells and increasing the presence of activate

27 acterized by an abundance of myeloid-derived suppressor cells and inhibition of cytotoxic T-cell infi

28 ecruitment of both monocytic myeloid-derived suppressor cells and macrophages, thereby promoting meta

29 by cell populations such as myeloid-derived suppressor cells and regulatory T cells, as well as immu

30 nt, including development of myeloid-derived suppressor cells and regulatory T cells; therefore, thes

31 gulatory mediators TGF-beta, myeloid-derived suppressor cells and regulatory T-cells.

32 LC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour growth.

33 on in cancer (in the form of myeloid-derived suppressor cells) and, more recently, infection.

34 withstanding the presence of myeloid-derived suppressor cells, and CD8(+) dendritic cells cross-prese

35 (pDCs), regulatory T cells, myeloid-derived suppressor cells, and CD8(+) regulatory T cells.

36 +) T cells and CD11(+)Gr1(+) myeloid-derived suppressor cells, and changes in the chemokine/cytokine

37 Kupffer cells, myeloid-derived suppressor cells, and liver dendritic cells both promote

38 themselves, dendritic cells, myeloid-derived suppressor cells, and macrophages.

39 cells, type II macrophages, myeloid-derived suppressor cells, and other immunosuppressive cells that

40 macrophages and granulocytic myeloid-derived suppressor cells, and protumor T-regulatory/Th17 cell re

41 es in regulatory T cells and myeloid-derived suppressor cells, and the leukemic cells themselves were

42 matopoietic stem cell niche, myeloid-derived suppressor cells, and the sympathetic nervous system.

43 n, and expansion of immature myeloid-derived suppressor cells are all contributory.

44 honuclear cells/granulocytic myeloid-derived suppressor cells are due to the loss of CD44 upon enzyma

45 inflammatory response and/or myeloid-derived suppressor cells are neutralized.

46 e deficits through compensatory trans-acting suppressors, cells are penalized in the long term by cha

47 r-associated macrophages and myeloid-derived suppressor cells, are abundant in the HCC microenvironme

48 xpansion of Gr-1(+) CD11b(+) myeloid-derived suppressor cells, as well as elevated levels of immune a

49 tion of CD11b+Gr1intF4/80int myeloid-derived suppressor cells at the resection margin and increased t

50 predominantly in neutrophil/myeloid-derived suppressor cells, but rarely in tumor cells.

51 xpands a heterogeneous population of myeloid suppressor cells capable of inhibiting T cell function.

52 in cargo of exosomes shed by myeloid-derived suppressor cells collected under high and low conditions

53 ted increased recruitment of myeloid-derived suppressor cells, consistent with protection of the epit

54 uding regulatory T cells and myeloid-derived suppressor cells, correlating with an increased therapeu

55 tivation of AKT, activation of the p53 tumor suppressor cell cycle checkpoint and cell death.

56 ater numbers of macrophages, myeloid-derived suppressor cells, dendritic cells, and granulocytes than

57 indicate that denileukin diftitox and other suppressor cell-depleting therapies may be useful adjunc

58 f phenformin on granulocytic myeloid-derived suppressor cell-driven immune suppression and support th

59 epletion of T-regulatory and myeloid-derived suppressor cells during TB infection.

60 s document the generation of myeloid-derived suppressor cells during TB, suggesting their role in TB

61 cell (DC) differentiation to myeloid-derived suppressor cell expansion during tumour progression.

62 d to the finding that alloantigen-specific T suppressor cells express IL-2 receptor (CD25) and that I

63 rogenic dendritic cells, and myeloid-derived suppressor cells, for the induction of transplantation t

64 lly and functionally, to the myeloid-derived suppressor cells found in cancer because they exerted a

65 henotypically similar to the myeloid-derived suppressor cells found in patients with cancer, have rec

66 Moreover, TAMs and myeloid-derived suppressor cells from MIF-deficient mice exhibit reduced

67 suppressor macrophages, and myeloid-derived suppressor cells, generated in vitro from the same mouse

68 reg), Th17, and granulocytic myeloid-derived suppressor cells (gMDSC) were increased significantly in

69 pe resembling granulocytic myeloid-dependent suppressor cells (gMDSCs).

70 equency of immunosuppressive myeloid-derived suppressor cells in a syngeneic TNBC mouse model.

71 s, the phenotype typical for myeloid-derived suppressor cells in cancer or immature myeloid cells (IM

72 und they differentiated into myeloid-derived suppressor cells in early metastatic sites of tumor-bear

73 sized causal role for IL-4Ralpha and myeloid suppressor cells in glioma development.

74 tively inhibits granulocytic myeloid-derived suppressor cells in spleens of tumor-bearing mice and ex

75 revealed the accumulation of myeloid-derived suppressor cells in the lung and liver.

76 only reduced tumor-promoting myeloid-derived suppressor cells in the lung, but also down-regulated th

77 ficiency, which also lessens myeloid-derived suppressor cells in the premetastatic niche, synergized

78 ercentage of macrophages and myeloid-derived suppressor cells in the tumor microenvironment.

79 neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvironment.

80 ines, including TGF-beta, by myeloid-derived suppressor cells in tumor-draining lymph nodes, leading

81 nulocytic (gMDSC) subsets of myeloid-derived suppressor cells infiltrate in the primary tumour and di

82 ell killing while decreasing myeloid-derived suppressor cell infiltration and IL10 production in the

83 splenic proliferation of bone marrow-derived suppressor cells, inhibiting the adaptive immune respons

84 the suppressive function of myeloid-derived suppressor cells, inhibits the release of IL-12 p70 by m

85 ta drives differentiation of myeloid-derived suppressor cells into protumorigenic terminally differen

86 aling mediates maturation of myeloid-derived suppressor cells into TDMMCs with high levels of cell su

87 erodimer ligands can recruit myeloid-derived suppressor cells into the skin, countering rather than p

88 othelial, haematopoietic and myeloid-derived suppressor cells is sufficient to cause regression of tu

89 y a balanced distribution of myeloid-derived suppressor cell-like and APC-like myeloid phenotypes and

90 Myeloid-derived suppressor cell-like fibrocytes were increased in COPD c

91 to the apparent expansion of myeloid-derived suppressor cell-like populations.

92 e monocytic and granulocytic myeloid-derived suppressor cells (M- and G-MDSCs) defined by their abili

93 in turn, activate monocytic myeloid-derived suppressor cells (M-MDSCs) via IL-13 secretion.

94 trophils, T cells, monocytic myeloid-derived suppressor cells (M-MDSCs), and group 2 innate lymphoid

95 myeloid cells expressing the myeloid-derived suppressor cell marker S100A9 only in a TN breast cancer

96 Factors responsible for myeloid-derived suppressor cell (MDSC) expansion and T-cell dysfunction

97 ociated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) infiltration in tumors via chemok

98 tomach, where they exhibited myeloid-derived suppressor cell (MDSC) markers and acquired the ability

99 s) and (ii) CD45(+) CD34(-) [myeloid-derived suppressor cell (MDSC)-like fibrocytes] cells in stable

100 c cells were driven toward a myeloid-derived suppressor cell (MDSC)-like phenotype by the GRO chemoki

101 d medium differentiated into myeloid derived suppressor cells (MDSC) (CD33(+)CD11b(+)HLA-DR(-/low)).

102 umors exhibit an increase in myeloid-derived suppressor cells (MDSC) and a decrease in T cells, indic

103 ve an increased frequency of myeloid derived suppressor cells (MDSC) and are at increased risk for ca

104 umulation of lung-associated myeloid-derived suppressor cells (MDSC) and MDSC-derived production of T

105 Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of imm

106 Myeloid-derived suppressor cells (MDSC) are a heterogeneous population o

107 Myeloid-derived suppressor cells (MDSC) are a major obstacle to promisin

108 Myeloid-derived suppressor cells (MDSC) are an immunosuppressive populat

109 Myeloid-derived suppressor cells (MDSC) are elevated in most individuals

110 Myeloid-derived suppressor cells (MDSC) are one of the major factors lim

111 Myeloid-derived suppressor cells (MDSC) contribute significantly to the

112 Myeloid-derived suppressor cells (MDSC) contribute to an immunosuppressi

113 Tumor-induced myeloid-derived suppressor cells (MDSC) contribute to immune suppression

114 Myeloid-derived suppressor cells (MDSC) contribute to immune suppression

115 Myeloid-derived suppressor cells (MDSC) expand in tumor-bearing hosts an

116 Myeloid-derived suppressor cells (MDSC) expanded with tumor progression

117 cells allowed generation of myeloid-derived suppressor cells (MDSC) from precursors in mouse bone ma

118 he expansion and function of myeloid-derived suppressor cells (MDSC) has not been determined.

119 Traditionally, myeloid-derived suppressor cells (MDSC) have been studied in regard to t

120 (CD11b(+)Ly6G(-)Ly6C(high)) myeloid-derived suppressor cells (MDSC) in chronically infected mice, wh

121 nction of tumor-infiltrating myeloid-derived suppressor cells (MDSC) in ganglioside-deficient tumors,

122 Accumulation of myeloid-derived suppressor cells (MDSC) in melanoma microenvironment is

123 st, it reduced the levels of myeloid-derived suppressor cells (MDSC) in mice bearing Lewis lung carci

124 induction of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC) in the peritoneum, which express

125 sociated with restoration of myeloid-derived suppressor cells (MDSC) in the tumor microenvironment, i

126 y, we show the importance of myeloid-derived suppressor cells (MDSC) in this process at bone metastat

127 cy may be the recruitment of myeloid-derived suppressor cells (MDSC) into the tumor microenvironment.

128 Myeloid derived suppressor cells (MDSC) produce nitric oxide (NO) and in

129 Myeloid-derived suppressor cells (MDSC) represent a unique cell populati

130 sue recruited CXCR2-positive myeloid-derived suppressor cells (MDSC) to form a premetastatic niche th

131 d CD4(+) helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurrent views on the

132 mobilization of granulocytic myeloid-derived suppressor cells (MDSC) to the breast cancer lung metast

133 gulatory T cells (Treg), and myeloid-derived suppressor cells (MDSC) were profiled by flow cytometry.

134 clitaxel to tumor-associated myeloid-derived suppressor cells (MDSC), (ii) MPO-regulated release, and

135 etic progenitor cells (HPC), myeloid-derived suppressor cells (MDSC), and dendritic cells is directly

136 T regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and exhausted T effector cells

137 mune suppression mediated by myeloid-derived suppressor cells (MDSC), as derived from cytokine induct

138 increases in CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSC), FoxP3(+) regulatory T cells, an

139 ory T lymphocytes (Treg) and myeloid-derived suppressor cells (MDSC), major components of these inhib

140 M), and CD11b(+)Gr-1 (LY6G)+ myeloid-derived suppressor cells (MDSC), respond to cancer-related stres

141 ated with an accumulation of myeloid-derived suppressor cells (MDSC), the numbers of which are reduce

142 ave previously reported that myeloid-derived suppressor cells (MDSC), which are a heterogeneous popul

143 Here we report that myeloid-derived suppressor cells (MDSC), which are classically linked to

144 Myeloid-derived suppressor cells (MDSC), which expand during states of e

145 ry T cells (Treg) and innate myeloid-derived suppressor cells (MDSC), which facilitate immune escape

146 nase activity, identified as myeloid-derived suppressor cells (MDSC).

147 ociated macrophages (TAM) or myeloid-derived suppressor cells (MDSC).

148 by inducing accumulation of myeloid-derived suppressor cells (MDSC).

149 expression is a hallmark of myeloid-derived suppressor cells (MDSC).

150 (DC), and Ly6C(+) or Ly6G(+) myeloid-derived suppressor cells (MDSC).

151 mmunosuppression mediated by myeloid-derived suppressor cells (MDSC).

152 including M2 macrophages and myeloid-derived suppressor cells (MDSC).

153 its the protumor function of myeloid-derived suppressor cells (MDSC).

154 (TAM), dendritic cells, and myeloid-derived suppressor cells (MDSC).

155 ly and functionally resemble myeloid-derived suppressor cells (MDSC).

156 TL) responses and are termed myeloid-derived suppressor cells (MDSC).

157 egulatory T cells (Treg) and myeloid-derived suppressor cells (MDSC).

158 d to induce the expansion of myeloid-derived suppressor cells (MDSC); however, little is known regard

159 Myeloid-derived suppressor cells (MDSCs) accumulate as a result of infla

160 ncreased in myeloid cells as myeloid-derived suppressor cells (MDSCs) accumulated, which was associat

161 ingly, a subset of monocytic myeloid-derived suppressor cells (MDSCs) also expressed CD2 and CREMalph

162 Recruitment of monocytic myeloid-derived suppressor cells (MDSCs) and differentiation of tumor-as

163 lammatory cells that include myeloid-derived suppressor cells (MDSCs) and IL-13(+) Th2 cells.

164 ive monocyte polarization to myeloid-derived suppressor cells (MDSCs) and M2-like macrophages.

165 latory mechanism mediated by myeloid-derived suppressor cells (MDSCs) and showed that MDSCs expanded

166 as phenotypically similar to myeloid-derived suppressor cells (MDSCs) and that suppressed T cell resp

167 ion of myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophage

168 Myeloid-derived CD11b(+)Gr1(+) suppressor cells (MDSCs) and tumor-associated macrophage

169 rating myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophage

170 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of my

171 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population

172 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population

173 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous, immature m

174 Myeloid-derived suppressor cells (MDSCs) are a naturally occurring immun

175 cancer metastasis, in which myeloid-derived suppressor cells (MDSCs) are an important participant.

176 Myeloid-derived suppressor cells (MDSCs) are emerging as potential promo

177 Myeloid-derived suppressor cells (MDSCs) are greatly expanded in cancer

178 Myeloid-derived suppressor cells (MDSCs) are highly prevalent inflammato

179 Myeloid derived suppressor cells (MDSCs) are immature cells of myeloid o

180 Myeloid-derived suppressor cells (MDSCs) are innate immune cells that me

181 Myeloid-derived suppressor cells (MDSCs) are key regulatory cells that c

182 Myeloid-derived suppressor cells (MDSCs) are known to play important rol

183 Myeloid-derived suppressor cells (MDSCs) are major regulators of T cell

184 Myeloid-derived suppressor cells (MDSCs) are myeloid progenitors and pre

185 Myeloid-derived suppressor cells (MDSCs) are one of the major negative r

186 Myeloid progenitor-derived suppressor cells (MDSCs) arise from myeloid progenitors

187 uction, with CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) as the most expanded population

188 ntiation and accumulation of myeloid-derived suppressor cells (MDSCs) both in vitro and in vivo.

189 Myeloid-derived suppressor cells (MDSCs) commonly expand during cancer a

190 Myeloid-derived suppressor cells (MDSCs) comprise immature myeloid popul

191 Myeloid-derived suppressor cells (MDSCs) constitute a key checkpoint tha

192 Myeloid-derived suppressor cells (MDSCs) dampen the immune response thor

193 The systemic accumulation of myeloid-derived suppressor cells (MDSCs) decreased significantly in flox

194 Myeloid-derived suppressor cells (MDSCs) described in cancer and inflamm

195 Myeloid-derived suppressor cells (MDSCs) expand in cancer-bearing hosts

196 CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) expand in the spleen during can

197 Myeloid-derived suppressor cells (MDSCs) favor tumor promotion, mainly b

198 nduce the differentiation of myeloid-derived suppressor cells (MDSCs) from myeloid progenitors.

199 The accumulation of myeloid-derived suppressor cells (MDSCs) has been observed in solid tumo

200 Myeloid-derived suppressor cells (MDSCs) have been characterized in seve

201 Myeloid-derived suppressor cells (MDSCs) have emerged as major regulator

202 understanding of the role of myeloid-derived suppressor cells (MDSCs) in cancer is becoming increasin

203 n immune-suppressive role of myeloid-derived suppressor cells (MDSCs) in melanoma has long been specu

204 iency causes infiltration of myeloid-derived suppressor cells (MDSCs) in multiple organs and subseque

205 ed iNKT cells cooperate with myeloid-derived suppressor cells (MDSCs) in protecting mice against the

206 entified a critical role for myeloid-derived suppressor cells (MDSCs) in S. aureus biofilm persistenc

207 The role of myeloid-derived suppressor cells (MDSCs) in the graft protection provide

208 t al show the involvement of myeloid-derived suppressor cells (MDSCs) in the pathogenesis of immune t

209 ion of the immunosuppressive myeloid-derived suppressor cells (MDSCs) in the spleen by alpha-GalCer t

210 es to understand the role of myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment a

211 greater absolute numbers of myeloid-derived suppressor cells (MDSCs) in tm24KO mice and showed that

212 dentify increased numbers of myeloid-derived suppressor cells (MDSCs) in untreated patients with chro

213 n shown to induce functional myeloid-derived suppressor cells (MDSCs) in vivo.

214 In cancer, increased myeloid-derived suppressor cells (MDSCs) induce detrimental immunosuppre

215 immune-suppressive activity, myeloid-derived suppressor cells (MDSCs) influence tumor progression in

216 Myeloid-derived suppressor cells (MDSCs) inhibit T-cell expansion and fu

217 h inhibiting infiltration of myeloid-derived suppressor cells (MDSCs) into colonic mucosa and tumors

218 n tumor microenvironments by myeloid-derived suppressor cells (MDSCs) is widely accepted.

219 cells, accumulation of donor myeloid-derived suppressor cells (MDSCs) mediated by ILC2 production of

220 xpansion of Gr-1(+) CD11b(+) myeloid-derived suppressor cells (MDSCs) occurring intraprostatically im

221 Myeloid-derived suppressor cells (MDSCs) play a critical role in promoti

222 Myeloid-derived suppressor cells (MDSCs) play a major role in cancer.

223 Myeloid-derived suppressor cells (MDSCs) play an important role in the r

224 Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous popul

225 ations produced by patients' myeloid-derived suppressor cells (MDSCs) support the development of RORg

226 lymphocyte antigen 6G (Ly6G) myeloid-derived suppressor cells (MDSCs) that caused myeloproliferative

227 of cells with similarity to myeloid-derived suppressor cells (MDSCs) that may have suppressed vaccin

228 of immunosuppressive CD33(+) myeloid-derived suppressor cells (MDSCs) that negatively correlated with

229 vestigated the potential for myeloid-derived suppressor cells (MDSCs) to suppress T cell-mediated imm

230 1(high)Ly-6C(+) granulocytic myeloid-derived suppressor cells (MDSCs) to the liver of HLA-DR4 transge

231 DCs and Gr-1(high)CD11c(neg) myeloid-derived suppressor cells (MDSCs) were enriched in GVHD target or

232 Myeloid-derived suppressor cells (MDSCs) were recently found to accumula

233 AR-deficient mice, monocytic myeloid-derived suppressor cells (MDSCs) were recruited to the liver.

234 restingly, immunosuppressive myeloid-derived suppressor cells (MDSCs) were recruited to tumor tissue

235 al by cotransplantation with myeloid-derived suppressor cells (MDSCs) without requirement of immunosu

236 were increased, notably the myeloid-derived suppressor cells (MDSCs), a CD11b(+) subset characterize

237 e paclitaxel on functions of myeloid-derived suppressor cells (MDSCs), chronic inflammatory mediators

238 G-F4/80(low)) with monocytic myeloid-derived suppressor cells (MDSCs), had similar morphology, and su

239 ovel subset of innate cells, myeloid-derived suppressor cells (MDSCs), has been described in cancer,

240 nally resemble tumor-induced myeloid-derived suppressor cells (MDSCs), indicating an essential role o

241 population of stromal cells, myeloid-derived suppressor cells (MDSCs), is present in tumors.

242 Two major populations of myeloid-derived suppressor cells (MDSCs), monocytic MDSCs (M-MDSCs) and

243 immune-inhibitory responses (myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs), an

244 and massive accumulation of myeloid-derived suppressor cells (MDSCs), which actively suppressed anti

245 tinct subset of neutrophilic myeloid-derived suppressor cells (MDSCs), which functionally suppress T

246 lation of tumor-infiltrating myeloid-derived suppressor cells (MDSCs), which suppress T cells and alt

247 ture myeloid cells, known as myeloid-derived suppressor cells (MDSCs).

248 icating that these cells are myeloid-derived suppressor cells (MDSCs).

249 These are characteristics of myeloid-derived suppressor cells (MDSCs).

250 T-effector cells and reduced myeloid-derived suppressor cells (MDSCs).

251 which drives mobilization of myeloid-derived suppressor cells (MDSCs).

252 e epigenetic modulators were myeloid-derived suppressor cells (MDSCs).

253 dendritic cells (moDCs), and myeloid-derived suppressor cells (MDSCs).

254 ll as regulatory T cells and myeloid-derived suppressor cells (MDSCs).

255 tivity of tumor-infiltrating myeloid-derived suppressor cells (MDSCs).

256 d did not depend on Tregs or myeloid-derived suppressor cells (MDSCs).

257 une cell infiltrates such as myeloid-derived suppressor cells (MDSCs).

258 y of cancer immunotherapy by myeloid-derived suppressor cells (MDSCs).

259 immature populations termed myeloid-derived suppressor cells (MDSCs).

260 ociated with the decrease of myeloid-derived suppressor cells (MDSCs).

261 trated from the circulation (myeloid-derived suppressor cells [MDSCs], monocyte-derived macrophages [

262 8.35; P = .01) and monocytic myeloid derived suppressor cells (mMDSC) (95% CI, 3.62-12.74; P = .001)

263 Monocytic myeloid-derived suppressor cells (mMDSC) are an important component of t

264 riven expansion of monocytic myeloid-derived suppressor cells (mMDSC) from human or mouse myeloid pro

265 creased numbers of monocytic myeloid-derived suppressor cells (Mo-MDSC) in psoriasis patients and exa

266 4(+) HLA-DR(-/low) monocytic myeloid-derived suppressor cells (Mo-MDSCs) have been shown to suppress

267 Human monocytic myeloid-derived suppressor cells (MO-MDSCs) within the hepatic compartme

268 cells, natural killer cells, myeloid-derived suppressor cells, neutrophils, or macrophages.

269 The increase in NK cell and myeloid-derived suppressor cell numbers was associated with increased bo

270 their murine counterparts, are highly potent suppressor cells of both CD4(+) and CD8(+) T cell respon

271 to generate ex vivo a subpopulation of human suppressor cells of monocytic origin, referred to as hum

272 Regulatory T-cells, natural suppressor cells of the immune system, control pro-infla

273 umor-associated macrophages, myeloid-derived suppressor cells, or inflammatory monocytes, functions o

274 ng combined approaches to deplete endogenous suppressor cell populations that can also expand effecto

275 secreted tissue signals and myeloid-derived suppressor cell populations were altered in surgically s

276 Regulatory B cells and myeloid-derived suppressor cells, previously shown to express CD38, were

277 atory T cell recruitment and myeloid-derived suppressor cell proliferation.

278 ammaR-dependent mechanism regulates CD8(+) T suppressor cell recruitment, limits immunopathogenesis,

279 high levels of granulocytic myeloid-derived suppressor cells resulted in loss of immunotherapeutic p

280 s, we identified a CD14/CD24 myeloid-derived suppressor cell subset with the capability of killing ac

281 cell death pathways, we found the monocytic suppressor-cell subset, but not the granulocytic subset,

282 s immune factors involved in myeloid-derived suppressor cell survival and trafficking.

283 CD4 T suppressor cells that ex vivo reverted to effector cells

284 This system employed an ion suppressor cell to desalt the chromatographic effluent o

285 ise to highly activated short-lived Klrg1(+) suppressor cells to optimize immune regulation and maint

286 ctional plasticity and can be converted from suppressor cells to pathogenic effector cells, enhancing

287 ulatory dendritic cells, and myeloid-derived suppressor cells to regulate alloimmunity, their potenti

288 recruitment of monocytes and myeloid-derived suppressor cells to the tumor microenvironment.

289 unosuppressive cells such as myeloid-derived suppressor cells, tolerogenic monocytes, and T regulator

290 er, significant expansion of myeloid-derived suppressor cells was detected in the recipients of CD47-

291 Although the number of myeloid-derived suppressor cells was increased in the lungs with metasta

292 CBD-induced suppressor cells were comprised of CD11b(+)Ly6-G(+)Ly6-C

293 ns of T-regulatory cells and myeloid-derived suppressor cells were observed in both rejection and tol

294 ygen species in granulocytic myeloid-derived suppressor cells, whereas the antioxidant N-acetylcystei

295 oration and were enriched in myeloid-derived suppressor cells which could be responsible for immunosu

296 We found that myeloid-derived suppressor cells, which are elevated in the course of ch

297 r-associated macrophages and myeloid-derived suppressor cells, which not only mediate immune suppress

298 aling responses in monocytic myeloid-derived suppressor cells, which was paired with their pronounced

299 effector T cells, Tregs, and myeloid-derived suppressor cells, while effector T cells expressed more

300 revealed a subpopulation of myeloid-derived suppressor cells within the CD11b(+) Gr-1(high) cell fra